Most Yorkshire girls given cancer jab Yorkshire Post Thu, 03 Sep 2009 14:01 PM PDT THREE in four girls in Yorkshire have been inoculated with a new jab to protect against a virus which can go on to cause cervical cancer. | Cancer victims encourage health care reform now Daily News Journal Thu, 03 Sep 2009 14:00 PM PDT Cancer survivors and those who have lost loved ones to cancer called on legislators in Washington to pass health care legislation that guarantees adequate, affordable insurance for people with cancer and for those who could get cancer. | MannKind to Present at Upcoming Conferences Business Wire via Yahoo! Finance Thu, 03 Sep 2009 14:00 PM PDT VALENCIA, Calif.----MannKind Corporation , focused on discovering, developing and commercializing treatments for diabetes and cancer, announced today that it will present at upcoming conferences. | Suns Raise $5,372 For Breast Cancer Awareness Through Pitching Pink Campaign OurSports Central Thu, 03 Sep 2009 13:59 PM PDT HAGERSTOWN, MD -- A testament to the continued success of their annual Pitching Pink fundraising campaign, the Hagerstown Suns presented a donation of $5,372 to Breast Cancer Awareness of Cumberland Valley earlier this week, using proceeds raised at the ballpark to support the fight against breast cancer. | Hyundai Hope On Wheels Donates $50K To Childrens Hospital WPXI Pittsburgh Thu, 03 Sep 2009 13:44 PM PDT Pittsburgh Pa. -- On Thursday morning, Childrenâs Hospital hosted the 2009 Hyundai Hope on Wheels event. Childhood cancer patients and their families who have received treatment at Childrenâs Hospital joined Hyundai and its dealers in presenting Dr. J. Anthony Graves with a check for $50,000. | Pancreatic Cancer Deaths Higher for Blacks MedicineNet.com Thu, 03 Sep 2009 13:30 PM PDT Title: Pancreatic Cancer Deaths Higher for Blacks Category: Health News Created: 9/2/2009 4:10:00 PM Last Editorial Review: 9/3/2009 | Genentech's Hedgehog Signal Inhibitor Helped Patients With Advanced Skin And Brain Cancers Medical News Today Thu, 03 Sep 2009 13:19 PM PDT A new type of experimental anti-cancer drug developed by Genentech, which inhibits the hedgehog signalling pathway, was effective in treating patients with advanced skin cancer. It was also very effective at first in treating a patient with an advanced type of brain cancer, and initial results were dramatic, but after a few months the cancer became resistant to the drug. | | |
|
No comments:
Post a Comment